Cue Biopharma Preferred Securities out of Shareholders Equity (Quarterly) Analysis

Cue Biopharma, Inc. (CUE)

0.302 +0.02 (+9.03%) USD | NASDAQ | Jan 16, 16:00

0.3052 0.00 (0.00%) After-Hours: 20:00

View Preferred Securities out of Shareholders Equity (Quarterly) for CUE.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Preferred Securities out of Shareholders Equity (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Preferred Securities out of Shareholders Equity (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Preferred Securities out of Shareholders Equity (Quarterly) Benchmarks

Start Trial

Insmed, Inc.	--
Puma Biotechnology, Inc.	--
Mersana Therapeutics, Inc. (DELISTED)	--
Adaptive Biotechnologies Corp.	--
NovaBay Pharmaceuticals, Inc.	--